BioLab Holdings, Inc

Industry

  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Drug Discovery Technologies
  • Digital Health
    • Disease Management
  • Pharmaceuticals
    • Drug Delivery

Other Names/Subsidiaries

  • BLS Labs
  • BLS Sales and Marketing
See more in Biomedtracker

Latest on BioLab Holdings, Inc

Generics Bulletin

US Pricing Pressure Spotlights Regulatory Compliance As Key To Indian Companies’ Performance

 
• By Vibha Ravi

Indian companies saw continued erosion of generic drug prices in the US during the second quarter of fiscal year 2023, which ends 31 March, management commentary from companies which have announced ea

Scrip

US Pricing Pressure Spotlights Regulatory Compliance As Key To Indian Companies’ Performance

 
• By Vibha Ravi

Indian companies saw continued erosion of generic drug prices in the US during the second quarter of fiscal year 2023, which ends 31 March, management commentary from companies which have announced ea